Bulletin
Investor Alert

Vertex Pharmaceuticals Inc.

NAS: VRTX

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Sep 25, 2020, 7:56 p.m.

/zigman2/quotes/202259802/composite

$

267.00

Change

-1.18 -0.44%

Volume

Volume 87,809

Quotes are delayed by 20 min

/zigman2/quotes/202259802/composite

Previous close

$ 263.13

$ 268.18

Change

+5.05 +1.92%

Day low

Day high

$260.52

$268.91

Open

52 week low

52 week high

$165.23

$306.08

Open

Insider Actions for Vertex Pharmaceuticals Inc.

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
08/25/2020 Margaret G. McGlynn
Director
3,707   Gift at $0 per share. 0
08/06/2020 David Matthew Altshuler
EVP, Global Research and CSO
310   Disposition at $272.6 per share. 84,506
08/06/2020 David Matthew Altshuler
EVP, Global Research and CSO
423   Disposition at $271.39 per share. 114,797
08/06/2020 David Matthew Altshuler
EVP, Global Research and CSO
490   Disposition at $270.12 per share. 132,358
08/06/2020 Michael J. Parini
EVP, Chief Adm, Leg & BD Off
311   Disposition at $272.53 per share. 84,756
08/06/2020 Michael J. Parini
EVP, Chief Adm, Leg & BD Off
422   Disposition at $271.45 per share. 114,551
08/06/2020 Michael J. Parini
EVP, Chief Adm, Leg & BD Off
490   Disposition at $270.13 per share. 132,363
08/06/2020 Reshma Kewalramani
CEO & President; Director
93   Disposition at $273.27 per share. 25,414
08/06/2020 Reshma Kewalramani
CEO & President; Director
487   Disposition at $272.76 per share. 132,834
08/06/2020 Reshma Kewalramani
CEO & President; Director
471   Disposition at $271.42 per share. 127,838
08/06/2020 Reshma Kewalramani
CEO & President; Director
870   Disposition at $270.36 per share. 235,213
08/06/2020 Reshma Kewalramani
CEO & President; Director
152   Disposition at $269.11 per share. 40,904
08/06/2020 Paul M. Silva
SVP & Controller
74   Disposition at $272.87 per share. 20,192
08/06/2020 Paul M. Silva
SVP & Controller
373   Disposition at $272.15 per share. 101,511
08/06/2020 Paul M. Silva
SVP & Controller
211   Disposition at $270.92 per share. 57,164
08/06/2020 Paul M. Silva
SVP & Controller
420   Disposition at $270.12 per share. 113,450
08/06/2020 David Matthew Altshuler
EVP, Global Research and CSO
1,223   Derivative/Non-derivative trans. at $155.57 per share. 190,262
08/06/2020 Michael J. Parini
EVP, Chief Adm, Leg & BD Off
1,223   Derivative/Non-derivative trans. at $155.57 per share. 190,262
08/06/2020 Reshma Kewalramani
CEO & President; Director
509   Derivative/Non-derivative trans. at $155.57 per share. 79,185
08/06/2020 Reshma Kewalramani
CEO & President; Director
1,564   Derivative/Non-derivative trans. at $187.53 per share. 293,296
08/06/2020 Paul M. Silva
SVP & Controller
612   Derivative/Non-derivative trans. at $155.57 per share. 95,208
08/06/2020 Paul M. Silva
SVP & Controller
466   Derivative/Non-derivative trans. at $187.53 per share. 87,388
08/03/2020 Amit K. Sachdev
EVP, Chief Patient Officer
751   Disposition at $279.18 per share. 209,664
08/03/2020 Amit K. Sachdev
EVP, Chief Patient Officer
690   Disposition at $278.25 per share. 191,992
08/03/2020 Amit K. Sachdev
EVP, Chief Patient Officer
500   Disposition at $276.96 per share. 138,480
08/03/2020 Stuart A. Arbuckle
EVP, Chief Commercial Officer
280   Disposition at $279.58 per share. 78,282
08/03/2020 Stuart A. Arbuckle
EVP, Chief Commercial Officer
689   Disposition at $278.72 per share. 192,038
08/03/2020 Stuart A. Arbuckle
EVP, Chief Commercial Officer
413   Disposition at $277.85 per share. 114,752
08/03/2020 Stuart A. Arbuckle
EVP, Chief Commercial Officer
171   Disposition at $276.4 per share. 47,264
08/03/2020 David Matthew Altshuler
EVP, Global Research and CSO
100   Disposition at $279.98 per share. 27,998
08/03/2020 David Matthew Altshuler
EVP, Global Research and CSO
605   Disposition at $279.19 per share. 168,909
08/03/2020 David Matthew Altshuler
EVP, Global Research and CSO
1,167   Disposition at $278.14 per share. 324,589
08/03/2020 David Matthew Altshuler
EVP, Global Research and CSO
458   Disposition at $276.84 per share. 126,792
08/03/2020 Michael J. Parini
EVP, Chief Adm, Leg & BD Off
730   Disposition at $279.41 per share. 203,969
08/03/2020 Michael J. Parini
EVP, Chief Adm, Leg & BD Off
1,100   Disposition at $278.13 per share. 305,943
08/03/2020 Michael J. Parini
EVP, Chief Adm, Leg & BD Off
500   Disposition at $276.98 per share. 138,490
08/03/2020 Paul M. Silva
SVP & Controller
19   Disposition at $279.61 per share. 5,312
08/03/2020 Paul M. Silva
SVP & Controller
429   Disposition at $278.92 per share. 119,656
08/03/2020 Paul M. Silva
SVP & Controller
310   Disposition at $277.73 per share. 86,096
08/03/2020 Paul M. Silva
SVP & Controller
51   Disposition at $276 per share. 14,076
08/03/2020 Amit K. Sachdev
EVP, Chief Patient Officer
1,941   Derivative/Non-derivative trans. at $86.52 per share. 167,935
08/03/2020 Stuart A. Arbuckle
EVP, Chief Commercial Officer
1,553   Derivative/Non-derivative trans. at $86.52 per share. 134,365
08/03/2020 David Matthew Altshuler
EVP, Global Research and CSO
2,330   Derivative/Non-derivative trans. at $86.52 per share. 201,591
08/03/2020 Michael J. Parini
EVP, Chief Adm, Leg & BD Off
2,330   Derivative/Non-derivative trans. at $86.52 per share. 201,591
08/03/2020 Paul M. Silva
SVP & Controller
809   Derivative/Non-derivative trans. at $86.52 per share. 69,994
07/13/2020 Michael J. Parini
EVP, Chief Adm, Leg & BD Off
100   Disposition at $296.48 per share. 29,648
07/13/2020 Michael J. Parini
EVP, Chief Adm, Leg & BD Off
300   Disposition at $295.38 per share. 88,614
07/13/2020 Michael J. Parini
EVP, Chief Adm, Leg & BD Off
800   Disposition at $294.57 per share. 235,656
07/13/2020 Michael J. Parini
EVP, Chief Adm, Leg & BD Off
200   Disposition at $292.76 per share. 58,552
07/13/2020 Michael J. Parini
EVP, Chief Adm, Leg & BD Off
100   Disposition at $290.65 per share. 29,065
07/13/2020 Michael J. Parini
EVP, Chief Adm, Leg & BD Off
200   Disposition at $288.57 per share. 57,714
07/13/2020 Michael J. Parini
EVP, Chief Adm, Leg & BD Off
100   Disposition at $286.57 per share. 28,657
07/13/2020 Michael J. Parini
EVP, Chief Adm, Leg & BD Off
225   Disposition at $285.67 per share. 64,275
07/13/2020 Michael J. Parini
EVP, Chief Adm, Leg & BD Off
100   Disposition at $284.28 per share. 28,428
07/13/2020 Paul M. Silva
SVP & Controller
100   Disposition at $295.78 per share. 29,578
07/13/2020 Paul M. Silva
SVP & Controller
250   Disposition at $294.99 per share. 73,747
07/13/2020 Paul M. Silva
SVP & Controller
200   Disposition at $294.18 per share. 58,836
07/13/2020 Paul M. Silva
SVP & Controller
50   Disposition at $291.97 per share. 14,598
07/13/2020 Paul M. Silva
SVP & Controller
100   Disposition at $287.86 per share. 28,786
07/13/2020 Paul M. Silva
SVP & Controller
60   Disposition at $285.71 per share. 17,142
07/13/2020 Paul M. Silva
SVP & Controller
100   Disposition at $284.56 per share. 28,456
07/13/2020 Michael J. Parini
EVP, Chief Adm, Leg & BD Off
2,125   Derivative/Non-derivative trans. at $90.29 per share. 191,866
07/13/2020 Paul M. Silva
SVP & Controller
860   Derivative/Non-derivative trans. at $90.29 per share. 77,649
07/10/2020 Charles F. Wagner
EVP & Chief Financial Officer
260   Disposition at $293.9 per share. 76,414
07/10/2020 Charles F. Wagner
EVP & Chief Financial Officer
400   Disposition at $292.86 per share. 117,144
07/10/2020 Charles F. Wagner
EVP & Chief Financial Officer
40   Disposition at $291.19 per share. 11,647
07/07/2020 Stuart A. Arbuckle
EVP, Chief Commercial Officer
2,786   Disposition at $300 per share. 835,800
07/07/2020 Stuart A. Arbuckle
EVP, Chief Commercial Officer
1,222   Derivative/Non-derivative trans. at $155.57 per share. 190,106
07/07/2020 Stuart A. Arbuckle
EVP, Chief Commercial Officer
1,564   Derivative/Non-derivative trans. at $187.53 per share. 293,296
06/30/2020 Jeffrey M. Leiden
Executive Chairman; Director
200   Disposition at $291.34 per share. 58,268
06/30/2020 Jeffrey M. Leiden
Executive Chairman; Director
2,534   Disposition at $290.51 per share. 736,152
06/30/2020 Jeffrey M. Leiden
Executive Chairman; Director
500   Disposition at $289.39 per share. 144,695
06/30/2020 Jeffrey M. Leiden
Executive Chairman; Director
1,318   Disposition at $287.91 per share. 379,465
06/30/2020 Jeffrey M. Leiden
Executive Chairman; Director
4,885   Disposition at $287.23 per share. 1,403,118
06/30/2020 Jeffrey M. Leiden
Executive Chairman; Director
8,321   Disposition at $286.13 per share. 2,380,887
06/30/2020 Jeffrey M. Leiden
Executive Chairman; Director
9,233   Disposition at $285.11 per share. 2,632,420
06/30/2020 Jeffrey M. Leiden
Executive Chairman; Director
5,801   Disposition at $284.14 per share. 1,648,296
06/03/2020 Diana L. McKenzie
Director
1,435   Award at $0 per share. 0
06/02/2020 Sangeeta N. Bhatia
Director
50   Disposition at $285.73 per share. 14,286
06/02/2020 Sangeeta N. Bhatia
Director
50   Disposition at $284.62 per share. 14,231
06/02/2020 Sangeeta N. Bhatia
Director
289   Disposition at $283.84 per share. 82,029
06/02/2020 Sangeeta N. Bhatia
Director
313   Disposition at $282.86 per share. 88,535
06/02/2020 Sangeeta N. Bhatia
Director
200   Disposition at $281.2 per share. 56,240
06/02/2020 Sangeeta N. Bhatia
Director
50   Disposition at $279.52 per share. 13,976
06/01/2020 Alan M. Garber
Director
699   Award at $0 per share. 0
06/01/2020 Sangeeta N. Bhatia
Director
1,398   Award at $0 per share. 0
06/01/2020 Lloyd A. Carney
Director
1,398   Award at $0 per share. 0
06/01/2020 Margaret G. McGlynn
Director
699   Award at $0 per share. 0

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
15 Purchases
62 Sales
20,331
57,530
Last 6 months
64 Purchases
295 Sales
442,195
533,864
Last 12 months
169 Purchases
647 Sales
1,408,937
1,512,330

Officers and Executives

Dr. Jeffrey M. Leiden
Executive Chairman
Dr. Reshma Kewalramani
President, Chief Executive Officer & Director
Mr. Charles F. Wagner
Chief Financial Officer & Executive Vice President
Dr. Carmen Bozic
Chief Medical Officer
Mr. Mike Tirozzi
Senior VP, Chief Information & Data Officer
Dr. David Matthew Altshuler
Chief Scientific Officer & EVP-Global Research
Mr. Michael J. Parini
Chief Legal & Administrative Officer, Executive VP
Dr. Riccardo Panicucci
Director-Foundation Development
Ms. Mary Kay Fenton
Vice President-Strategic Operations
Mr. Stuart A. Arbuckle
Chief Commercial Officer & Executive VP
Mr. Amit K. Sachdev
Chief Patient Officer & Executive Vice President
Mr. Ludovic Fenaux
Senior VP-International Commercial Operations
Mr. Damian W. Wilmot
Chief Risk & Compliance Officer
Mr. Paul M. Silva
SVP, Controller & Principal Accounting Officer
Mr. Michael Partridge
Senior Vice President-Investor Relations
Ms. Stephanie Franklin
Chief Human Resources Officer & Senior VP
Dr. Nia Tatsis
Senior Vice President & Chief Regulatory Officer
Ms. Diana L. McKenzie
Independent Director
Mr. Bruce I. Sachs
Lead Independent Director
Ms. Margaret G. McGlynn
Independent Director
Mr. Terrence C. Kearney
Independent Director
Mr. Yuchun Lee
Independent Director
Dr. Sangeeta N. Bhatia
Independent Director
Dr. Alan M. Garber
Independent Director
Mr. Lloyd A. Carney
Independent Director
Link to MarketWatch's Slice.